Search Results

• • 4 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo

  Authors:Diana P. English, Stefania Bellone, Carlton L. Schwab, Dana M. Roque, Salvatore Lopez, Ileana Bortolomai, et al.From:Cancer (Vol. 121, Issue 3) Peer-Reviewed

  Feb. 1, 2015 Report

   Citation Only

• Past, present and future targets for immunotherapy in ovarian cancer

  Authors:Carlton L Schwab, Diana P English, Dana M Roque, Monica Pasternak, and Alessandro D SantinFrom:Immunotherapy (Vol. 6, Issue 12) Peer-Reviewed

  Dec. 201412,401 words Report 1800LAuthor(s): Carlton L Schwab aff1 , Diana P English aff1 , Dana M Roque aff1 , Monica Pasternak aff1 , Alessandro D Santin [*] aff1 Keywords: adoptive transfer; CA125; EpCAM; mesothelin; NY-ESO-1; ovarian cancer;...

• Targeted therapy in the treatment of uterine serous carcinoma

  Authors:Carlton L Schwab and Alessandro D SantinFrom:Pharmacogenomics (Vol. 16, Issue 2) Peer-Reviewed

  Jan. 20152,131 words Report 1770LAuthor(s): Carlton L Schwab aff1 , Alessandro D Santin aff1 Keywords: HER2; PIK3CA; mTOR; targeted therapy; uterine serous carcinoma Endometrial cancer is the most common of gynecologic malignancies in the US...

• Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE[R]), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro

  Authors:Francesca Ferrari, Stefania Bellone, Jonathan Black, Carlton L. Schwab, Salvatore Lopez, Emiliano Cocco, et al.From:Journal of Experimental & Clinical Cancer Research (Vol. 34, Issue 1) Peer-Reviewed

  Oct. 17, 20155,417 words Article 1540LBackground Uterine and ovarian carcinosarcomas (CS) are rare but highly aggressive gynecologic tumors which carry an extremely poor prognosis. We evaluated the expression levels of EpCAM and the in vitro activity of...